Cargando…

Editorial: Advancing Science for Clinical Care in MDS

Detalles Bibliográficos
Autores principales:	Figueroa, Maria E., DeZern, Amy E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068944/ https://www.ncbi.nlm.nih.gov/pubmed/35530304 http://dx.doi.org/10.3389/fonc.2022.901118

Ejemplares similares

Are We Ready For “Triplet” Therapy in Higher-Risk MDS?
por: Brunner, Andrew M., et al.
Publicado: (2023)

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia
por: Ambinder, Alexander J., et al.
Publicado: (2022)

Validation of International Working Group response criteria in higher‐risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium
por: Komrokji, Rami S., et al.
Publicado: (2020)

Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype
por: Sallman, David A., et al.
Publicado: (2016)

The Coming of Age of Preclinical Models of MDS
por: Liu, Wei, et al.
Publicado: (2022)

COVID-19 Outcomes Among Participants in the NHLBI Myelodysplastic Syndromes (MDS) Natural History Study
por: Padron, Eric, et al.
Publicado: (2021)

Why Single-Cell Sequencing Has Promise in MDS
por: Zhang, Xuan, et al.
Publicado: (2021)

Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology
por: Karantanos, Theodoros, et al.
Publicado: (2021)

PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS (SELECT-MDS-1)
por: DeZern, A., et al.
Publicado: (2022)

What Clonal Hematopoiesis Can Teach Us About MDS
por: Chan, Irenaeus C. C., et al.
Publicado: (2022)

Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies
por: Avagyan, Serine, et al.
Publicado: (2022)

PP2A: The Achilles Heal in MDS with 5q Deletion
por: Sallman, David A., et al.
Publicado: (2014)

Editorial: Chordoma: advances in biology and clinical management
por: Gardner, Paul, et al.
Publicado: (2023)

Role of GFI1 in Epigenetic Regulation of MDS and AML Pathogenesis: Mechanisms and Therapeutic Implications
por: Möröy, Tarik, et al.
Publicado: (2019)

Comparative Study on Iron Content Detection by Energy Spectral CT and MRI in MDS Patients
por: Zhang, Yao, et al.
Publicado: (2021)

The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts
por: Choi, In Young, et al.
Publicado: (2023)

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS
por: Stahl, Maximilian, et al.
Publicado: (2023)

The use of carbon monoxide breath test to detect the effect of iron overload on erythrocyte lifespan in MDS
por: Zhang, Yao, et al.
Publicado: (2022)

Clinical Efficacy and Safety of Oral Decitabine/Cedazuridine in 133 Patients with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
por: Savona, Michael R., et al.
Publicado: (2020)

Editorial for special issue on advances in Actuarial Science and quantitative finance
por: Feng, Runhuan, et al.
Publicado: (2022)

Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN
por: Mestrum, Stefan G. C., et al.
Publicado: (2020)

Editorial: Reshaping the diagnostic process in oncology: science versus technology
por: Grizzi, Fabio, et al.
Publicado: (2023)

Editorial: Radiomics Advances Precision Medicine
por: Gao, Bo, et al.
Publicado: (2022)

Editorial: Advances in radiotherapy for prostate cancer
por: Kamran, Sophia C., et al.
Publicado: (2022)

Editorial: Psychosocial Advances in Neuro-Oncology
por: Ownsworth, Tamara, et al.
Publicado: (2015)

Editorial: Advances in Combination Tumor Immunotherapy
por: Curran, Michael A., et al.
Publicado: (2015)

Editorial: Advances in the treatment of Hodgkin lymphoma
por: Mei, Matthew, et al.
Publicado: (2023)

Editorial: The latest advances in transplantation for AML
por: Chiusolo, Patrizia, et al.
Publicado: (2023)

Editorial: Recent advances in liquid biopsy in colorectal cancer
por: Cardone, Claudia, et al.
Publicado: (2022)

Editorial: Quantitative Imaging for Clinical Decisions
por: deSouza, Nandita Maria, et al.
Publicado: (2022)

Editorial: Advances of Targeted Therapy in Gynecologic Malignancies
por: Qiu, Haifeng, et al.
Publicado: (2022)

Editorial: Advancements in immunology and immunotherapy for breast cancer
por: Sugie, Tomoharu, et al.
Publicado: (2022)

Editorial: Recent advances in the understanding of hepatocellular carcinogenesis
por: Banini, Bubu A., et al.
Publicado: (2022)

Editorial: Multimodal management of advanced gastric cancer
por: Garg, Pankaj Kumar, et al.
Publicado: (2022)

Editorial: Advances in Transoral Approaches for Laryngeal Cancer
por: Piazza, Cesare, et al.
Publicado: (2018)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Editorial: Advances in the Multidisciplinary Management of Oral Cancer
por: Paderno, Alberto, et al.
Publicado: (2021)

Editorial: Recent advances in cervical cancer radiotherapy
por: Varlotto, John Michael, et al.
Publicado: (2023)

Editorial: Advances in the treatment of chronic myeloid leukemia
por: Eşkazan, Ahmet Emre, et al.
Publicado: (2023)

Editorial: Advances in the understanding and treatment of cutaneous lymphoma
por: Bernardelli, Andrea, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_imvn17mj4abr7gff6sq1g9h6o5